ESMO 2024
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
LATEST
Study Highlights Improved Outcomes in Mandibular Reconstruction Using Patient-Specific Implants
2026-01-25
Study Explores Role of Peer Recovery Coaches in Substance Use Recovery Programs Across the United States
2026-01-25
Advancements in Genomic Classification of Corynebacterium diphtheriae Strains Address Microbial Resistance Challenges
2026-01-25



